Atlas Trials

A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure

Clinical trial NCT05952089 · COMPLETED

Trial details

NCT number
NCT05952089
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure With Reduced Ejection Fraction
Start date
2023-08-17
Primary completion
2024-03-15
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.